Paclitaxel poliglumex. Cell Therapeutics/Chugai Pharmaceutical.
作者信息
Man Martha, Rugo Hope
机构信息
University of California San Francisco Comprehensive Cancer Center, 2nd Floor BCC, 1600 Divisidero Street, San Francisco, CA 94115, USA.
出版信息
IDrugs. 2005 Sep;8(9):739-54.
PMID:16118697
Abstract
Cell Therapeutics Inc, under license from the MD Anderson Cancer Center and in collaboration with Chugai Pharmaceutical Co Ltd (the Japanese subsidiary of Roche), is developing paclitaxel poliglumex, an intravenous poly-(alpha-L-glutamic acid) conjugate of paclitaxel for the potential treatment of solid tumors.
摘要
Zotero 插件